Efficacy of Mindfulness-Based Relapse Prevention

基于正念的复发预防的功效

• 批准号: 7033623
• 负责人: Gordon ALAN Marlatt
• 金额: $ 22.62万
• 依托单位: UNIVERSITY OF WASHINGTON
• 依托单位国家: 美国
• 财政年份: 2006
• 资助国家: 美国
• 起止时间: 2006-06-15 至 2008-05-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7033623
• 关键词: alcohols; clinical research; clinical trials; cognitive behavior therapy; community; coping; emotions; handbook; meditation; prevention

DESCRIPTION (provided by applicant): The broad, long-term objective of the current research is to improve treatment for alcohol and other drug (AOD) use disorders through development of an innovative alternative approach to preventing AOD relapse. The specific aims of the research are 1) To develop a manual and therapist adherence/competence measures to standardize delivery of a Mindfulness-Based Relapse Prevention (MBRP) program for post-treatment relapse prevention of AOD problems, which will be patterned after Mindfulness-Based Cognitive Therapy for Depression (Segal, Teasdale & Williams, 2002) and incorporate cognitive-behavioral relapse prevention strategies (Daley & Marlatt, 1997); 2) To conduct a pilot randomized clinical trial to assess the feasibility of recruiting and retaining individuals for a large scale study and to determine effect size of MBRP in comparison to cognitive-behavioral group relapse prevention based on Marlatt's Relapse Prevention model (RP) alone (Daley & Marlatt, 1997). Both MBRP and RP conditions will be compared to a treatment as usual control group (TAU) in a sample of participants enrolled in continuing care following Intensive Outpatient Treatment, at baseline, post-treatment, 2-, and 4-months following the baseline assessment; and 3) Evaluate potential mediators of MBRP and RP treatment efficacy. We hypothesize that both MBRP and RP will be more efficacious than TAU. We hypothesize MBRP efficacy will be mediated by meta-cognitive processes, thought suppression, locus of control, skills to cope with urges and cravings, negative affect and meditation practice. We hypothesize RP efficacy will be mediated by self-efficacy, negative affect and coping abilities. This research builds on over 25 years of developing and implementing RP interventions. MBRP incorporates specific alcohol and drug-focused cognitive therapy techniques with an additional emphasis on mindfulness skills, and builds upon the Investigator's prior work on meditation-based interventions.

描述（由申请人提供）： 目前研究的广泛，长期目标是通过开发一种创新的替代方法来预防酒精和其他药物（AOD）使用障碍的治疗。本研究的具体目的是：1）开发一个手册和治疗师依从性/能力测量标准，以规范基于正念的复发预防（MBRP）计划的实施，该计划将以基于正念的抑郁症认知治疗为模式，用于预防AOD问题的治疗后复发（Segal，Teasdale &威廉姆斯，2002），并纳入认知行为复发预防策略（Daley & Marlatt，1997）; 2）进行一项试点随机临床试验，以评估招募和保留个体进行大规模研究的可行性，并确定MBRP与认知-行为组复发预防仅基于Marlatt复发预防模型（RP）（Daley & Marlatt，1997）。在基线、治疗后、基线评估后2个月和4个月，将MBRP和RP状况与常规治疗对照组（TAU）进行比较; 3）评价MBRP和RP治疗疗效的潜在介质。我们假设MBRP和RP都比TAU更有效。我们假设MBRP的疗效将介导的元认知过程，思想抑制，控制点，技能，以科普冲动和渴望，负面影响和冥想练习。我们假设RP效能感将通过自我效能感、负性情感和应对能力来介导。这项研究建立在超过25年的开发和实施RP干预措施的基础上。MBRP结合了特定的酒精和药物为重点的认知治疗技术，额外强调正念技能，并建立在研究者先前对基于冥想的干预措施的研究基础上。